Posted inBiotechnology
Seafood intake may help close nutrition gaps in Brazil, study suggests
Brazil’s long coastline and rich marine life should, in theory, make seafood a nutritional powerhouse. Yet a new nationwide analysis…
Posted inBiotechnology
Latent Profiles of Age-Friendly Cities in Colombia Linked to Later-Life Ageism
A new study in Colombia is using a sophisticated statistical lens to map how older adults perceive the age-friendliness of…
Posted inBiotechnology
SACF and GILA multi-site study evaluates CRISPR/Cas9-edited cell transformation in vitro
A new multi-site study published in Gene Therapy reports that two streamlined assays—SACF and GILA—can improve how scientists evaluate whether…
Posted inBiotechnology
Danish and Swedish Study Links Early Hospital Contacts to Childhood Cancer Mortality
Hospitals are not only places where childhood cancer is treated—they also generate records of earlier health encounters. A new population-based…
Posted inBiotechnology
Gene base editing reverses Huntington’s disease in mice
CHAMPAIGN, Ill. — Researchers at the University of Illinois Urbana-Champaign report that a precision gene-editing strategy can reduce the toxic…
Posted inBiotechnology
‘We have what we need to grow:’ Biogen CEO happy to ease off the M&A for a while
Biogen's business development team may have been busy in recent years, but CEO Christopher Viehbacher is easing off the acquisitions…
Posted inBiotechnology
Optical methods tackle complex optimization problems faster and more efficiently
Osaka, Japan—Optimization is the quiet engine behind everything from planning transport routes to organizing huge datasets. But as these problems…
Posted inBiotechnology
New Einstein puzzle variant uncovers surprising physics
Aperiodic order is back in the spotlight. A team at the Institute of Industrial Science, The University of Tokyo has…
Posted inBiotechnology
Novo Nordisk fails to dismiss lawsuit over CagriSema readout
Novo Nordisk’s attempt to dismiss a lawsuit about its CagriSema readout has failed, with the judge ruling that parts of…
Posted inBiotechnology
Processa acquires Vidya for potential BTK inhibitor rival to Novartis’ Rhapsido
Processa Pharmaceuticals has made a push into the autoimmune space via the acquisition of Vidya Therapeutics, which delivers a potential…